医学
以兹提米比
PCSK9
2型糖尿病
内科学
糖尿病
优势比
冠状动脉疾病
等位基因
低密度脂蛋白受体
内分泌学
他汀类
胆固醇
脂蛋白
生物信息学
遗传学
基因
生物
作者
Luca A. Lotta,Stephen J. Sharp,Stephen Burgess,John R. B. Perry,Isobel D. Stewart,Sara M. Willems,Jian’an Luan,Eva Ardanáz,Larraitz Arriola,Beverley Balkau,Heiner Boeing,Panos Deloukas,Nita G. Forouhi,Paul W. Franks,Sara Grioni,Rudolf Kaaks,Timothy J. Key,Carmen Navarro,Peter M. Nilsson,Kim Overvad
出处
期刊:JAMA
[American Medical Association]
日期:2016-10-04
卷期号:316 (13): 1383-1383
被引量:405
标识
DOI:10.1001/jama.2016.14568
摘要
In this meta-analysis, exposure to LDL-C-lowering genetic variants in or near NPC1L1 and other genes was associated with a higher risk of type 2 diabetes. These data provide insights into potential adverse effects of LDL-C-lowering therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI